Skip Nav Destination
Article navigation
Editorial Views|
July 1993
Should We Use Muscle Biopsy to Diagnose Malignant Hyperthermia Susceptibility?
Marllyn Green Larach, M.D., F.A.A.P.
Marllyn Green Larach, M.D., F.A.A.P.
Search for other works by this author on:
Director, The North American Malignant Hyperthermia Registry, Associate Professor of Anesthesia and Pediatrics, Pennsylvania State University College of Medicine, P.O. Box 850, Hershey, Pennsylvania 17033
Anesthesiology July 1993, Vol. 79, 1–4.
Citation
Marllyn Green Larach; Should We Use Muscle Biopsy to Diagnose Malignant Hyperthermia Susceptibility?. Anesthesiology 1993; 79:1–4 doi: https://doi.org/10.1097/00000542-199307000-00002
Download citation file:
Citing articles via
Most Viewed
Related Articles
Muscle Biopsy and In Vitro Contracture Test in Subjects with Idiopathic HyperCKemia
Anesthesiology (October 2008)
Comparison of the Segregation of the RYR1 C1840T Mutation with Segregation of the Caffeine/Halothane Contracture Test Results for Malignant Hyperthermia Susceptibility in a Large Manitoba Mennonite Family
Anesthesiology (February 1996)
Evidence for Susceptibility to Malignant Hyperthermia in Patients with Exercise-induced Rhabdomyolysis
Anesthesiology (January 2001)
Sodium Channel in Human Malignant Hyperthermia
Anesthesiology (May 1997)
Detection of Proton Release from Cultured Human Myotubes to Identify Malignant Hyperthermia Susceptibility
Anesthesiology (November 2002)
